Will AbbVie’s AndroGel lawsuits ever be settled?
In October 2018, settlements in the AbbVie’s AndroGel lawsuits FINALLY appear ready to resolve. The drug company and plaintiffs’ lawyers are dotting the i’s and crossing the t’s on a settlement agreement that would resolve thousands of testosterone cases. (June 2019 Update: $775 million.)
Is AbbVie’s settlement the last hold out in MDL?
More than six months after a reported settlement was reached involving AbbVie, Inc., the last remaining hold out in multidistrict litigation (MDL) over testosterone replacement therapies, the majority of cases in the MDL still had not been closed as of early April 2019, according to the court’s list of member cases .
How much did AbbVie pay for the heart attack case?
In that trial, the federal jury ordered AbbVie to pay $3.2 million to a Chicago man who suffered a heart attack after using the testosterone replacement therapy.
How many AndroGel products liability lawsuits are there?
In addition to the thousands of federal claims, AbbVie says it also faces roughly 200 AndroGel products liability lawsuits filed in various state courts.
What is the Androgel lawsuit?
With thousands of plaintiffs having sued the pharmaceutical company AbbVie over alleged improper marketing of its testosterone drug AndroGel, one aspect of the AndroGel fiasco that has gotten less attention publicly has been the use of AndroGel by top athletes in an effort to get gain an illicit edge on their competition. Now, with reports that years-old emails directly tie Nike CEO Mark Parker to secret experiments using AndroGel on Nike-backed runners, the AndroGel-doping scandal has reached the highest levels of sports business.
When was Androgel approved?
The United States Food and Drug Administration (FDA) approved AndroGel in 2000 for use in treating a relatively rare condition known as hypogonadism, a form of severe testosterone deficiency that can be caused by illness, trauma, or genetic factors.
How many MDL cases have been closed?
In total, the testosterone-drug MDL has included roughly 7,900 cases, of which nearly 2,900 have closed, leaving approximately 5,000 testosterone-drug lawsuits yet to be resolved, according to a count of member cases conducted by TheLawFirm.com.
What is the MDL in Sanofi?
Among the core claims facing Sanofi and other makers of testosterone replacement therapies (TRTs) in multidistrict litigation (MDL) taking place in the Northern District of Illinois is the allegation that the companies invested heavily in multimillion-dollar marketing schemes specifically designed to convince men suffering from natural, age-related declines in testosterone levels that they were in need of pharmaceutical intervention in order to return to their former masculinity and vigor, unnecessarily exposing themselves to an increased risk of serious side effects while the drug companies reaped the heady profits, which quickly ran into the billions of dollars.
Why did Robert Nolte take Androgel?
The case involved plaintiff Robert Nolte, who developed a pulmonary embolism after beginning to take AndroGel at the age of 72 in an effort to boost low testosterone levels. Attorneys for Nolte alleged that the plaintiff specifically inquired about the drug to his doctor after seeing advertisements promoting AndroGel’s ability to return vitality to the lives of men Nolte’s age. Nolte’s attorneys further allege that AbbVie engaged in such a marketing campaign without adequately studying the potential health effects of AngroGel on patients Nolte’s age.
When did the Androgel case close?
The run of recent case resolutions in multidistrict litigation (MDL) over testosterone-replacement therapies (TRTs) including AbbVie’s AndroGel continued through mid-February as more than thirty additional cases closed February 18 , according to the court’s list of member cases .
How many cases have been resolved in 2019?
Over 900 cases have been resolved since the first of the year, and over 1,400 cases have closed since November 1, 2019. The flood of recent case resolutions followed months of apparently little movement in the MDL. For example, no cases were closed in the period between July 26 and September 13, 2019.
What are the side effects of Androgel?
The low testosterone therapy medication AndroGel gas been associated with severe medical side effects including heart attacks, pulmonary embolism, stroke, and cardiac arrest. Numerous victims of unsafe medications including testosterone replacement gels contact our law offices in search of legal help in protecting their right to compensation for their injuries. One of the most common and most important questions that are asked by individuals who speak with our attorneys is “what is the value of my case,” or, “how much do you think my case will settle for”. Determining the Value of a Case: Every case is different comprising of a set of unique characteristics which play a significant role in any future settlement negotiations with pharmaceutical companies or jury verdicts. A brief description of important factors contributing to the value of a case AndroGel and other unsafe low testosterone therapy medications has been is provided below.
What is per diem in medical terms?
Per Diem: The amount of day an victims has and will continue to suffer physical pain and mental anguish due the use of a defective drug multiplied by a calculation of how much per day an individual suffering that type of harm should be compensated for.
What was the first testosterone lawsuit?
In that trial, the federal jury ordered AbbVie to pay $3.2 million to a Chicago man who suffered a heart attack after using the testosterone replacement therapy. A separate jury had previously awarded the same defendant, Jesse Mitchell, more than $150 million in punitive and compensatory damages, but that initial verdict was overturned and the case was sent back for a second trial.
Where are testosterone lawsuits filed?
While testosterone lawsuits have been filed in many states, most of those lawsuits were transferred to the U.S. District Court in the District of Northern Illinois to participate in multidistrict litigation (MDL) proceedings. The MDL process lets plaintiffs file individual lawsuits, allowing them to seek damages related to their personal experience.
Why Are People Filing Testosterone Lawsuits?
Thousands of men have filed testosterone lawsuits against manufacturers like AbbVie, Allergan, and Endo Pharmaceuticals because of harmful side effects. Lawsuit claims against testosterone replacement therapy (TRT) products - which are often prescribed to treat low testosterone levels ("Low-T") in men - include an increased risk of blood clots, stroke, pulmonary embolism, heart disease, and prostate cancer, among other potentially deadly complications.
How many lawsuits have been filed against testosterone?
Manufacturers faced more than 7,800 lawsuits, paying $200 million in settlements thus far, with thousands more pending.
Is Androgel a lawsuit?
AndroGel testosterone lawsuits have been extremely high-profile, given the large number of cases filed against AbbVie Inc., a division of Abbott Laboratories. However, a number of other products and companies have also found themselves at the heart of legal claims.
Did Endo Pharmaceuticals pay $200 million?
Endo Pharmaceuticals: In June 2018, Endo announced a master settlement agreement in their testosterone cases. Though they did not publicly disclose the total amount, they did increase their legal reserves to $200 million to cover the agreement.
When did Eli Lilly settle its case?
Eli Lilly: In December 2017 , Eli Lilly announced a global settlement to resolve all testosterone cases against it worldwide, before its first case had gone to trial.